These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9196876)

  • 1. Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases.
    Perosa F; Scudeletti M; Imro MA; Dammacco F; Luccarelli G; Indiveri F
    Clin Exp Rheumatol; 1997; 15(2):201-10. PubMed ID: 9196876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human CD4-internal antigen anti-idiotypic monoclonal antibody: induction of a CD4-specific response in humans.
    Perosa F; Scudeletti M; Imro MA; Dammacco F; Indiveri F
    J Immunol; 1996 May; 156(9):3563-9. PubMed ID: 8617987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4 antibody therapy in systemic lupus erythematosus.
    Wofsy D; Carteron NL
    Semin Immunol; 1990 Nov; 2(6):419-25. PubMed ID: 2104279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe systemic lupus erythematosus with anti-CD4 monoclonal antibody.
    Hiepe F; Volk HD; Apostoloff E; von Baehr R; Emmrich F
    Lancet; 1991 Dec; 338(8781):1529-30. PubMed ID: 1683954
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of safety and the immune response to the CD4 "internal antigen" mouse anti-idiotypic Mab 16D7 in four patients with SLE.
    Perosa F; Luccarelli G; Scudeletti M; Cutolo M; Indiveri F; Dammacco F
    J Clin Immunol; 2002 Jan; 22(1):13-22. PubMed ID: 11958589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal-antibody therapy in systemic vasculitis.
    Mathieson PW; Cobbold SP; Hale G; Clark MR; Oliveira DB; Lockwood CM; Waldmann H
    N Engl J Med; 1990 Jul; 323(4):250-4. PubMed ID: 2366834
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapeutic approach to rheumatoid arthritis with anti-idiotypic antibodies to HLA-DR4.
    Quagliata F; Schenkelaars EJ; Ferrone S
    Isr J Med Sci; 1993; 29(2-3):154-9. PubMed ID: 8468170
    [No Abstract]   [Full Text] [Related]  

  • 8. CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination.
    Deckert PM; Ballmaier M; Lang S; Deicher H; Schedel I
    J Immunol; 1996 Jan; 156(2):826-33. PubMed ID: 8543839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD4 treatment of patients with rheumatoid arthritis. Is there still a place for this treatment principle in RA?
    Kalden JR
    Clin Exp Rheumatol; 1994; 12 Suppl 11():S67-9. PubMed ID: 7768057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients.
    Goldberg D; Morel P; Chatenoud L; Boitard C; Menkes CJ; Bertoye PH; Revillard JP; Bach JF
    J Autoimmun; 1991 Aug; 4(4):617-30. PubMed ID: 1777012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoclonal antibodies for treating autoimmune diseases].
    Takeno M; Sakane T
    Nihon Rinsho; 1997 Jun; 55(6):1543-8. PubMed ID: 9200946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
    Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
    Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4.
    Wofsy D; Seaman WE
    J Immunol; 1987 May; 138(10):3247-53. PubMed ID: 3106478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-idiotypic monoclonal antibodies reacting with idiotope on isolated-denatured chains of an anti-CD4 monoclonal antibody.
    Perosa F; Ferrone S; Dammacco F
    Immunology; 1991 Dec; 74(4):748-50. PubMed ID: 1783432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of anti-idiotypic antibodies in the induction of experimental systemic lupus erythematosus in mice.
    Mendlovic S; Fricke H; Shoenfeld Y; Mozes E
    Eur J Immunol; 1989 Apr; 19(4):729-34. PubMed ID: 2659371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells.
    Herzog C; Walker C; Müller W; Rieber P; Reiter C; Riethmüller G; Wassmer P; Stockinger H; Madic O; Pichler WJ
    J Autoimmun; 1989 Oct; 2(5):627-42. PubMed ID: 2572230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A therapeutic anti-CD4 monoclonal antibody inhibits T cell receptor signal transduction in mouse autoimmune cardiomyopathy.
    Wang ZH; Liao YH; Yuan J; Zhang L; Wang M; Zhang JH; Liu ZP; Dong JH
    Chin Med J (Engl); 2007 Aug; 120(15):1319-25. PubMed ID: 17711737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of anti-mouse antibodies in thrombocytopenic patients with autoimmune disorders.
    Clofent-Sanchez G; Laroche-Trainean J; Lucas S; Rispal P; Pellegrin JL; Nurden P; Nurden A
    Hum Antibodies; 1997; 8(2):50-9. PubMed ID: 9289388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of autoimmune disease with monoclonal anti-CD4 antibodies.
    Waldor MK
    Immunol Ser; 1989; 45():573-86. PubMed ID: 2577329
    [No Abstract]   [Full Text] [Related]  

  • 20. Paradoxic effect of anti-CD4 therapy on lacrimal gland disease in MRL/Mp-lpr/lpr mice.
    Jabs DA; Burns WH; Prendergast RA
    Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):246-50. PubMed ID: 8550330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.